Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

GMP Audit Findings

SOPs Routinely Bypassed in Practice: GMP Non-Adherence Risks and Remedies

Posted on By

SOPs Routinely Bypassed in Practice: GMP Non-Adherence Risks and Remedies Operational SOP Bypass in Pharmaceutical Facilities: A Hidden GMP Threat Introduction to the Audit Finding 1. Informal Practices Operators often develop their own shortcuts, deviating from the approved SOPs. 2. Silent Deviation Culture When SOPs are ignored routinely, deviations become normalized and go undocumented. 3….

Read More “SOPs Routinely Bypassed in Practice: GMP Non-Adherence Risks and Remedies” »

GMP Audit Findings, Non-Adherence

Missing Acceptance Criteria or Critical Limits in SOPs: A GMP Documentation Flaw

Posted on By

Missing Acceptance Criteria or Critical Limits in SOPs: A GMP Documentation Flaw SOPs Without Acceptance Criteria or Critical Limits: A Key GMP Documentation Deficiency Introduction to the Audit Finding 1. Vague Instructions Some SOPs describe procedures but fail to specify the required acceptance criteria or tolerances. 2. Critical Limit Omissions Parameters like temperature, pH, or…

Read More “Missing Acceptance Criteria or Critical Limits in SOPs: A GMP Documentation Flaw” »

GMP Audit Findings, Poor Writing

Non-User-Friendly SOPs in Pharma: Clarity Issues and Compliance Risks

Posted on By

Non-User-Friendly SOPs in Pharma: Clarity Issues and Compliance Risks Clarity and Comprehension Challenges in SOPs: A Barrier to GMP Compliance Introduction to the Audit Finding 1. Difficult Language Many SOPs are written in overly complex or technical language that frontline operators struggle to understand. 2. Disorganized Structure Unclear formatting and lack of visual hierarchy make…

Read More “Non-User-Friendly SOPs in Pharma: Clarity Issues and Compliance Risks” »

GMP Audit Findings, Poor Writing

Undefined Abbreviations and Acronyms in SOPs: A Risk to GMP Documentation Clarity

Posted on By

Undefined Abbreviations and Acronyms in SOPs: A Risk to GMP Documentation Clarity Clarity Risk from Undefined Abbreviations and Acronyms in SOPs Introduction to the Audit Finding 1. Unexplained Terms SOPs often use abbreviations or acronyms like “OOS”, “BMR”, or “CAPA” without defining them. 2. User Confusion Operators and new employees may misinterpret terms, increasing the…

Read More “Undefined Abbreviations and Acronyms in SOPs: A Risk to GMP Documentation Clarity” »

GMP Audit Findings, Poor Writing

Staff Unaware of Recent SOP Changes: A Compliance and Training Risk

Posted on By

Staff Unaware of Recent SOP Changes: A Compliance and Training Risk Failure to Communicate SOP Revisions to Staff: A Hidden Compliance Risk Introduction to the Audit Finding 1. SOP Revisions Not Communicated Staff continued following outdated SOPs due to lack of communication of recent changes. 2. Training Logs Incomplete No documented evidence that employees were…

Read More “Staff Unaware of Recent SOP Changes: A Compliance and Training Risk” »

GMP Audit Findings, SOP Training Failure

Incomplete Training Records: A Critical Compliance Gap in GMP Environments

Posted on By

Incomplete Training Records: A Critical Compliance Gap in GMP Environments GMP Risk from Incomplete Training Records and Documentation Gaps Introduction to the Audit Finding 1. Training Not Fully Documented Records of employee training are either missing, incomplete, or lack essential details. 2. SOP Training Without Signature Personnel have received training but have not signed acknowledgement…

Read More “Incomplete Training Records: A Critical Compliance Gap in GMP Environments” »

GMP Audit Findings, SOP Training Failure

No Refresher Training on Critical SOPs: Risk to Compliance and Competency

Posted on By

No Refresher Training on Critical SOPs: Risk to Compliance and Competency Absence of Refresher Training on Critical SOPs: A Risk to GMP Compliance Introduction to the Audit Finding 1. Training Stagnation Employees undergo initial training but are not retrained on critical SOPs over time. 2. Compliance Erosion As procedures evolve, lack of refresher training results…

Read More “No Refresher Training on Critical SOPs: Risk to Compliance and Competency” »

GMP Audit Findings, SOP Training Failure

No Policy for Electronic Signatures: A Data Integrity Red Flag in GMP Systems

Posted on By

No Policy for Electronic Signatures: A Data Integrity Red Flag in GMP Systems Missing Electronic Signature Policy: A Risk to Data Integrity and GMP Compliance Introduction to the Audit Finding 1. Undefined e-Signature Protocols Organizations lack written procedures governing electronic signatures used in GMP operations. 2. Violation of 21 CFR Part 11 Absence of a…

Read More “No Policy for Electronic Signatures: A Data Integrity Red Flag in GMP Systems” »

Data Integrity Gaps, GMP Audit Findings

Data Integrity Controls Missing in Process SOPs: A Critical GMP Risk

Posted on By

Data Integrity Controls Missing in Process SOPs: A Critical GMP Risk Absence of Data Integrity Controls in Process SOPs: GMP Compliance Jeopardized Introduction to the Audit Finding 1. Unstructured Data Handling Process SOPs often lack instructions on data capture, review, or archival in compliance with ALCOA principles. 2. Informal Record Practices Operators maintain critical records…

Read More “Data Integrity Controls Missing in Process SOPs: A Critical GMP Risk” »

Data Integrity Gaps, GMP Audit Findings

SOPs Don’t Define Time-Stamped Entry Protocols: A GMP Documentation Deficiency

Posted on By

SOPs Don’t Define Time-Stamped Entry Protocols: A GMP Documentation Deficiency Time-Stamped Entries Missing in SOPs: A Critical Data Integrity Lapse Introduction to the Audit Finding 1. Omission of Timestamp Procedures Many SOPs fail to instruct personnel to include dates and times when recording GMP data. 2. Traceability Risks Without timestamps, it is impossible to verify…

Read More “SOPs Don’t Define Time-Stamped Entry Protocols: A GMP Documentation Deficiency” »

Data Integrity Gaps, GMP Audit Findings

Posts pagination

Previous 1 … 3 4 5 … 12 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme